Background: The evaluation and management of neonatal respiratory pathologies require precise and careful diagnostic approaches, particularly in preterm infants who are at higher risk of respiratory complications. This research compares lung ultrasound (LUS) and chest X-ray for diagnosing and monitoring respiratory conditions in preterm and term neonates.

Methods: We conducted a prospective analysis of the imaging practices for neonatal respiratory pathologies in a cohort of 82 preterm and term infants with a gestational age ranging from 31-41 weeks presenting with respiratory distress syndrome (RDS) diagnostically categorized based on clinical and paraclinical investigations, who were admitted to the neonatal intensive care unit (NICU) immediately after birth.

Results: The most common diagnosis was moderate RDS, which affected 17 neonates, followed by moderate transient tachypnea of the newborn (TTN) in 16 patients, severe RDS in 14 patients and meconium aspiration syndrome (MAS) in 12 patients. Additionally, seven patients presented with mild RDS and six were diagnosed with congenital pneumonia. There were four cases of severe TTN, four cases of mild TTN and only two cases of pneumothorax. This study identified the ultrasound and radiological findings and aimed to highlight the current trend in the evaluation and management of respiratory conditions in preterm and term neonates. The results demonstrate an increasing trend in the use of ultrasound due to its advantages, especially in preterm patients who are at higher risk of respiratory impairment.

Conclusion: The benefits of ultrasound, including absence of radiation and dynamic imaging capabilities, make it a valuable tool for ongoing assessment and management. While X-rays remain an important imaging tool in certain clinical scenarios, their use should be judicious to minimize radiation exposure. These findings support the continued integration of ultrasound in neonatal practice and suggest further research into optimizing imaging protocols to improve long-term outcomes for neonates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834845PMC
http://dx.doi.org/10.26574/maedica.2024.19.4.718DOI Listing

Publication Analysis

Top Keywords

neonatal respiratory
12
preterm term
12
respiratory
8
evaluation management
8
respiratory pathologies
8
higher risk
8
risk respiratory
8
respiratory conditions
8
conditions preterm
8
ttn cases
8

Similar Publications

Background: There is growing evidence that the occurrence and severity of respiratory diseases in children are related to the concentration of air pollutants. Nonetheless, evidence regarding the association between short-term exposure to air pollution and outpatient visits for respiratory diseases in children remains limited. Outpatients cover a wide range of disease severity, including both severe and mild cases, some of which may need to be transferred to inpatient treatment.

View Article and Find Full Text PDF

Background: Sepsis affects 25 million children and neonates annually, causing significant mortality and morbidity. Early identification and treatment are crucial for improving outcomes. Identifying children at risk is challenging due to clinical heterogeneity and overlap with other conditions.

View Article and Find Full Text PDF

Objective: This systematic review aimed to analyze, in neonates, the effects of high-frequency oscillatory ventilation (HFOV) with volume-targeted (VT) compared with conventional HFOV.

Sources: The authors searched PubMed, EMBASE, Cochrane, and ClinicalTrials.gov from inception until August 4th, 2024, to identify studies comparing HFOV with and without VT in neonates under 44 weeks corrected age.

View Article and Find Full Text PDF

Caffeine-clarithromycin coadministration and hyperlactatemia in a young infant: a case report.

Crit Care Sci

March 2025

Division of Critical Care Medicine, Department of Pediatrics, Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo - São Paulo (SP), Brazil.

Apnea is a major complication of acute respiratory tract infection in young infants and may lead to the need for ventilatory support. Caffeine is methylxanthine, which is considered the mainstay of pharmacologic treatment for apnea of prematurity. On the basis of neonatal guidelines, caffeine has been used as a respiratory stimulant for the treatment of acute respiratory tract infection-related apnea, despite low evidence of its ability to improve clinical outcomes.

View Article and Find Full Text PDF

Background: COVID-19, caused by SARS-CoV-2, was first documented in Japan in January 2020. We previously reported an increased risk of rhinovirus infections among children during the early phase of the COVID-19 pandemic. Here, we assessed the impact of COVID-19 on respiratory virus infections after SARS-CoV-2 spread nationwide.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!